SHARE

The U.S. healthcare system spends roughly $190 billion yearly on bodily therapies prescribed to deal with muscular and skeletal problems, and Sword Well being has raised $eight million in a brand new spherical of financing to slash these prices.

The New York-based firm was based in Europe 4 years in the past and lately relocated to the U.S. the place spending on musculoskeletal problems has skyrocketed to grow to be the second costliest ailment in America, the corporate mentioned.

Sword Well being focuses on 5 key pathologies — decrease again ache, shoulder ache, neck ache and bodily remedy within the wake of knee and hip substitute surgical procedures.

“Decrease again ache is a very powerful one by way of continual ache, then knee and shoulder ache” says Sword Well being founder and chief government Virgilio Bento.

Khosla Ventures led the spherical with undisclosed angel buyers. It’s the primary funding for Sword because it raised a $4.6 million seed spherical final April.

Bento launched the corporate after figuring out the shortage of availability of fine bodily remedy when his brother was recovering from a automotive accident and wanted entry to raised care.

The corporate has a {hardware} answer that’s arrange in session with a specialist both remotely or within the residence. The specialist will monitor a consumer of Sword Well being’s system of wearable units on a pill that’s outfitted with the corporate’s software program. After guiding a affected person by way of a remedy session, the affected person can then carry out the workout routines on their very own within the consolation of their residence.

Since its launch the corporate has handled 1,000 sufferers with its know-how, in response to Bento.

Sword isn’t the one firm that’s seeking to minimize prices for bodily remedy. One other European transplant to U.S. shores, Hinge Well being, grabbed a $26 million spherical about eight months in the past to deal with the American market with digital remedies for musculoskeletal ailments.

Sword, which has places of work in New York, San Francisco, and Porto mentioned that it could use the brand new cash partly for scientific validation of its therapies. The corporate has already revealed a examine in “Nature Scientific Experiences”, which reviewed the efficacy of the corporate’s therapy routine for sufferers who’d had whole knee substitute surgical procedures. 

“We already proved we may make the not possible doable by growing a brand new know-how many thought unthinkable,” mentioned Bento, in a press release. “With this spherical we need to go from the doable to the inevitable.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here